Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kalbe Farma Tbk (KLBF) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kalbe Farma TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kalbe Farma Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 197.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 96.7K). Which is the better fit depends on your goals.

KLBFOBAT
Market Cap
33T167.37B
Volume
98.44M96.7K
Lot
984.38K967
Turnover
70.64B23.82M
Average Price
717.58246.34
Value
70.64B23.82M
Indicative Equilibrium Price
720248
Indicative Equilibrium Volume
43.62K41

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KLBF
View details
OBAT
View details

About Kalbe Farma Tbk

PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.

Read more on KLBF

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT